Abstract:The development of safe and effective delivery systems is critical for the clinical applications of siRNA-based therapeutics. Polymer-based vectors have garnered significant attention owing to their structural flexibility and functional tunability. Polyethyleneimine (PEI) has been extensively studied for nucleic acid delivery; nevertheless, its high cytotoxicity has posed challenges for clinical applications. In this study, we have reported poly(glycidyl amine) (PGAm), a linear PEI analogue, demonstrating remarkable siRNA delivery efficacy and improved biocompatibility. By introducing three aromatic moieties (tyrosine, p-hydroxybenzenepropanoic acid, and phenylalanine) at varying ratios to further modify PGAms, we successfully constructed a library comprising 36 PGAm-based carriers. In vitro evaluations revealed that PGAm-based carriers exhibited significantly enhanced biocompatibility and reduced non-specific protein absorption in comparison to PEI25k. Among them, 10 modified PGAms achieved a knockdown of target gene expressions exceeding 80%, and 26 modified PGAms maintained over 70% cell viability when utilized for the in vitro delivery of siRNA to HeLa cells. Explorations into the structure-activity relationship of PGAm-based polyplex nanoparticles (NPs) indicated that the siRNA delivery efficacy of NPs depended on factors such as the molecular weight of PGAm precursors, the type of modifying moieties, and the modification ratio. Furthermore, it was demonstrated that two top-performing NPs, namely 2T100/siLuc and 2A50/siLuc, exhibited potent silencing of target genes in tumors following i.v. injection into mice bearing HeLa-Luc xenografts. The in vivo efficacy of the selected NPs was further validated by a remarkable anti-cancer effect when employed for the delivery of siRNA targeting polo-like kinase 1 (siPLK1) to mice with PC-3 xenograft tumors. The intravenous administration of NPs resulted in a substantial inhibition of tumor growth without significant toxicity. These findings demonstrate the feasibility of employing PGAm in siRNA delivery and provide valuable insights for the development of efficient siRNA carriers based on PGAm.

Biodegradable Multiamine Polymeric Vector for Sirna Delivery.

Biodegradable Nanoparticles of Mpeg-Plga-pll Triblock Copolymers As Novel Non-Viral Vectors for Improving Sirna Delivery and Gene Silencing.

Copolymer of Poly(Ethylene Glycol) and Poly((L)-Lysine) Grafting Polyethylenimine Through A Reducible Disulfide Linkage for Sirna Delivery

Novel aromatic moieties-modified poly(glycidyl amine)s with potent siRNA delivery and cancer treatment effect

Polycation-detachable Nanoparticles Self-Assembled from Mpeg-Pcl-g-ss-pdmaema for in Vitro and in Vivo Sirna Delivery.

Integration of Polylactide into Polyethylenimine Facilitates the Safe and Effective Intracellular siRNA Delivery

Self-assembled Biodegradable Micellar Nanoparticles of Amphiphilic and Cationic Block Copolymer for Sirna Delivery.

Biologically Responsive Carrier-Mediated Anti-Angiogenesis Shrna Delivery for Tumor Treatment

Efficient Delivery of Small Interfering RNA into Cancer Cells Using Dodecylated Dendrimers

Tumor Acidity-Sensitive Polymeric Vector for Active Targeted Sirna Delivery.

Dendrimer Nanovectors for Sirna Delivery

Low-weight Polyethylenimine Cross-Linked 2-Hydroxypopyl-β-cyclodextrin and Folic Acid As an Efficient and Nontoxic Sirna Carrier for Gene Silencing and Tumor Inhibition by VEGF Sirna

Mono-methoxy-poly(3-hydroxybutyrate-co-4-hydroxybutyrate)-graft-hyper-branched Polyethylenimine Copolymers for Sirna Delivery.

Synthesis and Characterization of Quaternized Poly(β-amino Ester) for Highly Efficient Delivery of Small Interfering RNA.

Bioreducible, Arginine-Rich Polydisulfide-Based Sirna Nanocomplexes with Excellent Tumor Penetration for Efficient Gene Silencing.

Structural contributions of blocked or grafted poly(2-dimethylaminoethyl methacrylate) on PEGylated polycaprolactone nanoparticles in siRNA delivery.

Size- and Surface- Dual Engineered Small Polyplexes for Efficiently Targeting Delivery of Sirna.

A Dual Targeting Dendrimer-Mediated Sirna Delivery System for Effective Gene Silencing in Cancer Therapy.

Self-assembly Nanomicelles Based on Cationic Mpeg-Pla-b-polyarginine(r15) Triblock Copolymer for Sirna Delivery.

Self-assembly of Amphiphilic Phospholipid Peptide Dendrimer-Based Nanovectors for Effective Delivery of Sirna Therapeutics in Prostate Cancer Therapy

Preparation and Characterization of Polymeric Nanoparticles for Sirna Delivery to Down-Regulate the Expressions of Exogenous and Endogenous Target Genes.